Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

The Ageing Adipose Paradox: Implications for Metabolic Health.

Matar DB., Elahi MA., Nassar WK., Alotaibi MI., Murphy D., Fakhoury HMA.

Narrative Review on Type 2 Diabetes, published in Diabetes Obes Metab (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Diabetes Obes Metab (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42366180
DOI
10.1111/dom.71037

Abstract (original English)

Preadipocyte commitment to the adipogenic lineage declines markedly with advancing age, while triglyceride accumulation in hypertrophied existing adipocytes persists or expands. This creates a dissociation between adipogenic capacity and lipid-buffering demand, progressively weakening depot metabolic competence and contributing to systemic insulin resistance. This review examines the molecular mechanisms linking impaired adipose tissue plasticity during ageing to metabolic decline, and appraises therapeutic strategies that may restore adipose progenitor competence or limit downstream metabolic dysfunction. Ageing adipose tissue is characterized by four interlocking defects. First, transcriptional reprogramming, including induction of the inhibitory CCAAT/enhancer-binding protein β-LIP isoform through CUG triplet repeat-binding protein 1, together with reduced C/EBPα and peroxisome proliferator-activated receptor γ activity, shifts progenitors away from differentiation and toward hypertrophic lipid storage. Second, SIRT7 opposes SIRT1 in regulating adipogenic commitment, implicating sirtuin and NAD + dysregulation in the age-related adipogenic deficit. Third, nuclear lamina remodelling restricts chromatin accessibility at adipogenic loci. Fourth, senescent cells accumulate in ageing depots and generate a senescence-associated secretory phenotype enriched in interleukin-6, tumour

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansAgingAdipose TissueAdipogenesisAnimalsAdipocytesInsulin Resistance

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research